logo

Clinical Trial Calendar

Share
Company Name Audentes Therapeutics, Inc.
Event Name Preliminary data Phase 1 / 2 clinical study of AT342 (VALENS)
Indication Crigler-Najjar
Outcome Date
Outcome
Result Date Q2 2018
News
http://investors.audentestx.com/phoenix.zhtml?c=254280&p=irol-newsArticle&ID=2316918
Return to Clinical Trial Calendar